First drug approved for rare condition that inflames blood vessels
(PHYSorg.com Medicine & Health)

(HealthDay)-Nucala (mepolizumab) has been approved by the U.S. Food and Drug Administration as the first remedy to treat adults with eosinophilic granulomatosis with polyangiitis, a rare autoimmune disease that leads to inflammation of the blood vessels.